JSL
REGN icon

JT Stratford LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

JT Stratford LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Sell
769
-6
-0.8% -$4.08K 0.05% 222
2026
Q1 		$599K Sell
775
-33
-4% -$25.3K 0.08% 196
2025
Q4 		$624K Sell
808
-902
-53% -$613K 0.08% 192
2025
Q3 		$961K Sell
1,710
-1,113
-39% -$629K 0.13% 153
2025
Q2 		$1.48M Sell
2,823
-362
-11% -$202K 0.22% 102
2025
Q1 		$2.02M Sell
3,185
-218
-6% -$150K 0.36% 61
2024
Q4 		$2.42M Buy
3,403
+394
+13% +$331K 0.4% 49
2024
Q3 		$3.16M Sell
3,009
-84
-3% -$93.5K 0.54% 35
2024
Q2 		$3.25M Buy
3,093
+1,128
+57% +$1.09M 0.6% 33
2024
Q1 		$1.89M Buy
1,965
+476
+32% +$453K 0.38% 66
2023
Q4 		$1.31M Buy
1,489
+18
+1% +$14.8K 0.3% 87
2023
Q3 		$1.21M Buy
1,471
+382
+35% +$300K 0.31% 87
2023
Q2 		$782K Sell
1,089
-1,157
-52% -$892K 0.21% 117
2023
Q1 		$1.85M Buy
2,246
+261
+13% +$197K 0.53% 47
2022
Q4 		$1.43M Buy
1,985
+1,179
+146% +$870K 0.46% 60
2022
Q3 		$555K Sell
806
-126
-14% -$79.3K 0.2% 101
2022
Q2 		$551K Buy
932
+72
+8% +$46.8K 0.17% 107
2022
Q1 		$601K Sell
860
-268
-24% -$170K 0.18% 103
2021
Q4 		$712K Buy
1,128
+465
+70% +$286K 0.19% 101
2021
Q3 		$401K Buy
+663
New +$412K 0.12% 144

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JT Stratford LLC's REGN Position: Q2 2026 in Review

JT Stratford LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 0.77% in Q2 2026, selling an estimated $4.08K and leaving 769 shares worth $480K. The position accounts for 0.05% of the portfolio, ranked #222.

JT Stratford LLC first reported a position in REGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.25M in Q2 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • JT Stratford LLC held 769 shares of Regeneron Pharmaceuticals worth $480K as of Q2 2026.
  • JT Stratford LLC sold 6 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.08K.
  • Regeneron Pharmaceuticals made up 0.05% of JT Stratford LLC's portfolio in Q2 2026, its #222 holding.
  • JT Stratford LLC first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • JT Stratford LLC's Regeneron Pharmaceuticals position peaked at $3.25M in Q2 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on JT Stratford LLC's 13F filing for Q2 2026, filed 14 Aug 2026.